The Impact of COVID-19 is included in Ventricular Assist Device Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Ventricular Assist Device Trends and Forecast
The future of the global ventricular assist device market looks promising with opportunities in the bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy applications. The global ventricular assist device market is expected to reach an estimated $3.2 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are rising prevalence of heart failure and growing number of patients with cardiovascular disease.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Ventricular Assist Device by Segment
The study includes a forecast for the global ventricular assist device by design, product, application, end use, and region.
Ventricular Assist Device Market by Design [Shipment Analysis by Value from 2018 to 2030]:
• Transcutaneous Ventricular Assist Devices
• Implantable Ventricular Assist Devices
Ventricular Assist Device Market by Product [Shipment Analysis by Value from 2018 to 2030]:
• Left Ventricular Assist Devices (LVADs)
• Right Ventricular Assist Devices (RVADs)
• Biventricular Assist Devices (BIVADs)
Ventricular Assist Device Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Bridge-to-Transplant
• Destination Therapy
• Bridge-to-Recovery
• Bridge to Candidacy Therapy
Ventricular Assist Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Ambulatory Surgery Centers
• Hospital
• Others
Ventricular Assist Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Ventricular Assist Device Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ventricular assist device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ventricular assist device companies profiled in this report include-
• Abbott Laboratories
• Corewave
• Bivacor
• Carmat
• Jarvik Heart
Ventricular Assist Device Market Insights
Lucintel forecasts that implantable ventricular assist device is expected to witness the higher growth over the forecast period due to its rising usage among patients with heart issue to improve the pumping function of the heart.
Within this market, destination therapy is expected to witness the highest growth.
North America is expected to witness highest growth over the forecast period due to existence of strong healthcare system and presence of key players in the region.
Features of the Global Ventricular Assist Device Market
Market Size Estimates: Ventricular assist device market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Ventricular assist device market size by various segments, such as by design, product, application, end use, and region in terms of value ($B).
Regional Analysis: Ventricular assist device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different designs, products, applications, end uses, and regions for the ventricular assist device market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ventricular assist device market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the ventricular assist device market size?
Answer: The global ventricular assist device market is expected to reach an estimated $3.2 billion by 2030.
Q2. What is the growth forecast for ventricular assist device market?
Answer: The global ventricular assist device market is expected to grow with a CAGR of 10.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the ventricular assist device market?
Answer: The major drivers for this market are rising prevalence of heart failure and growing number of patients with cardiovascular disease.
Q4. What are the major segments for ventricular assist device market?
Answer: The future of the ventricular assist device market looks promising with opportunities in the bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy applications.
Q5. Who are the key ventricular assist device market companies?
Answer: Some of the key ventricular assist device companies are as follows:
• Abbott Laboratories
• Corewave
• Bivacor
• Carmat
• Jarvik Heart
Q6. Which ventricular assist device market segment will be the largest in future?
Answer: Lucintel forecasts that implantable ventricular assist device is expected to witness the higher growth over the forecast period due to its rising usage among patients with heart issue to improve the pumping function of the heart.
Q7. In ventricular assist device market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to existence of strong healthcare system and presence of key players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the ventricular assist device market by design (transcutaneous ventricular assist devices and implantable ventricular assist devices), product (left ventricular assist devices, right ventricular assist devices, and biventricular assist devices), application (bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy), end use (ambulatory surgery centers, hospital, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Ventricular Assist Device Market, Ventricular Assist Device Market Size, Ventricular Assist Device Market Growth, Ventricular Assist Device Market Analysis, Ventricular Assist Device Market Report, Ventricular Assist Device Market Share, Ventricular Assist Device Market Trends, Ventricular Assist Device Market Forecast, Ventricular Assist Device Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Ventricular Assist Device Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Ventricular Assist Device Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Ventricular Assist Device Market by Design
3.3.1: Transcutaneous Ventricular Assist Devices
3.3.2: Implantable Ventricular Assist Devices
3.4: Global Ventricular Assist Device Market by Product
3.4.1: Left Ventricular Assist Devices (LVADs)
3.4.2: Right Ventricular Assist Devices (RVADs)
3.4.3: Biventricular Assist Devices (BIVADs)
3.5: Global Ventricular Assist Device Market by Application
3.5.1: Bridge-to-Transplant
3.5.2: Destination Therapy
3.5.3: Bridge-to-Recovery
3.5.4: Bridge to Candidacy Therapy
3.6: Global Ventricular Assist Device Market by End Use
3.6.1: Ambulatory Surgery Centers
3.6.2: Hospital
3.6.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Ventricular Assist Device Market by Region
4.2: North American Ventricular Assist Device Market
4.2.2: North American Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
4.3: European Ventricular Assist Device Market
4.3.1: European Ventricular Assist Device Market by Design: Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices
4.3.2: European Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
4.4: APAC Ventricular Assist Device Market
4.4.1: APAC Ventricular Assist Device Market by Design: Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices
4.4.2: APAC Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
4.5: ROW Ventricular Assist Device Market
4.5.1: ROW Ventricular Assist Device Market by Design: Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices
4.5.2: ROW Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Ventricular Assist Device Market by Design
6.1.2: Growth Opportunities for the Global Ventricular Assist Device Market by Product
6.1.3: Growth Opportunities for the Global Ventricular Assist Device Market by Application
6.1.4: Growth Opportunities for the Global Ventricular Assist Device Market by End Use
6.1.5: Growth Opportunities for the Global Ventricular Assist Device Market by Region
6.2: Emerging Trends in the Global Ventricular Assist Device Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Ventricular Assist Device Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Ventricular Assist Device Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Abbott Laboratories
7.2: Corewave
7.3: Bivacor
7.4: Carmat
7.5: Jarvik Heart
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Ventricular Assist Device Market Report.